Antimicrobial susceptibility of clinical isolates of Acinetobacter baumannii.

[1]  B. Suh,et al.  In vitro activity of β-lactamase inhibitors against clinical isolates of Acinetobacter species , 1995 .

[2]  B. Kreiswirth,et al.  Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam , 1994, The Lancet.

[3]  E. Stobberingh,et al.  Comparative in-vitro activity of piperacillin-tazobactam against recent clinical isolates, a Dutch national multicentre study. , 1994, The Journal of antimicrobial chemotherapy.

[4]  H. R. Chang,et al.  Antimicrobial susceptibilities of clinical isolates of Acinetobacter baumannii from Singapore , 1994, Antimicrobial Agents and Chemotherapy.

[5]  A. Tsakris,et al.  In-vitro activity of ampicillin/sulbactam against multiresistant Acinetobacter calcoaceticus var. anitratus clinical isolates. , 1994, The Journal of antimicrobial chemotherapy.

[6]  Y. Siegman-Igra,et al.  Nosocomial acinetobacter meningitis secondary to invasive procedures: report of 25 cases and review. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  A. Schulze,et al.  Antimicrobial susceptibility of Acinetobacter species , 1993, Antimicrobial Agents and Chemotherapy.

[8]  B. Berger,et al.  Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. , 1993, The Journal of infectious diseases.

[9]  J. Vila,et al.  In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii , 1993, Antimicrobial Agents and Chemotherapy.

[10]  M. Obara,et al.  Mechanisms of resistance to β-lactam antibiotics in Acinetobacter calcoaceticus , 1991 .

[11]  T. Nakae,et al.  Outer membrane permeability of Acinetobacter calcoaceticus and its implication in antibiotic resistance. , 1991, The Journal of antimicrobial chemotherapy.

[12]  Y. Buisson,et al.  Nosocomial outbreaks due to amikacin-resistant tobramycin-sensitive Acinetobacter species: correlation with amikacin usage. , 1990, The Journal of hospital infection.

[13]  G. Eliopoulos,et al.  Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830). , 1989, Diagnostic microbiology and infectious disease.

[14]  W. Traub,et al.  Antimicrobial drug susceptibility of clinical isolates of Acinetobacter species (A. baumannii, A. haemolyticus, genospecies 3, and genospecies 6) , 1989, Antimicrobial Agents and Chemotherapy.

[15]  T. Stibolt,et al.  Multiple intensive care unit outbreak of Acinetobacter calcoaceticus subspecies anitratus respiratory infection and colonization associated with contaminated, reusable ventilator circuits and resuscitation bags. , 1988, The American journal of medicine.

[16]  J F Vieu,et al.  Epidemiology of nosocomial infections due to Acinetobacter calcoaceticus. , 1987, The Journal of hospital infection.

[17]  Patrick A. D. Grimont,et al.  Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov. and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffii , 1986 .

[18]  R. Smego Endemic nosocomial Acinetobacter calcoaceticus bacteremia. Clinical significance, treatment, and prognosis. , 1985, Archives of internal medicine.

[19]  C. Carlier,et al.  Transferable plasmid-mediated antibiotic resistance in Acinetobacter. , 1983, Plasmid.

[20]  F. Kayser,et al.  Transposon-mediated multiple antibiotic resistance in Acinetobacter strains , 1982, Antimicrobial Agents and Chemotherapy.

[21]  T. Saito,et al.  beta-Lactamase and beta-lactam antibiotics resistance in acinetobacter anitratum (syn: A. calcoaceticus). , 1977, The Journal of antibiotics.